Patent Assignment
Reel/Frame 062154/0488
Assignment of Assignor's Interest
Recorded: 2022-12-20
Pages: 3
Assignor
NUCHEM THERAPEUTICS INC.
Executed: 2021-05-17
Assignee
VIGIL NEUROSCIENCE, INC.
ONE BROADWAY SUITE 07-300, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Heterocyclic Compounds as Triggering Receptor Expressed on Myeloid Cells 2 Agonists and Methods of Use
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 20, 2022
From: HOUZE, JONATHAN B.
To: VIGIL NEUROSCIENCE, INC.
Reel/Frame 062154/0090 →
Assignment of Assignor's Interest
Dec 20, 2022
From: BOS, MAXENCE; MANCUSO, JOHN; FRANZONI, IVAN
To: NUCHEM THERAPEUTICS INC.
Reel/Frame 062154/0228 →
Assignment of Assignor's Interest
Dec 20, 2022
From: CZABANIUK, LARA C.; HOPPER, TIMOTHY; PANTELEEV, JANE; RESCOURIO, GWENAELLA
To: AMGEN INC.
Reel/Frame 062172/0357 →